يحاول ذهب - حر
Mounjaro as good as older drug on heart-attack risk
August 01, 2025
|Mint Mumbai
A trial of Eli Lilly & Co.'s blockbuster diabetes drug Mounjaro fell short of expectations that it would do a better job of preventing heart attacks and strokes than its older medicine Trulicity.
A head-to-head study of the two treatments—Lilly's largest and longest of Mounjaro to date—was designed to prove what's called non-inferiority, that Mounjaro was an acceptable alternative when it comes to reducing risks from major cardiovascular events compared with Trulicity.
While it achieved that target, the study dashed investors' hopes that Mounjaro would be meaningfully better than its older drug. "There's no mention of superiority, which was also tested for by Lilly," said Bloomberg Intelligence analyst Michael Shah. "So it will likely be received negatively by the market."
Shares in the obesity-drug maker dropped as much as 5.3% in premarket trading in New York. Lilly's shares were down nearly 2% this year as of Wednesday's close, compared with an 8% rise in the S&P 500.
هذه القصة من طبعة August 01, 2025 من Mint Mumbai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Mumbai
Mint Mumbai
Indian firms in crisis mode as conflict in Gulf spirals
Indian companies with operations in West Asia spent the weekend tracking their employees and gauging the impact on their businesses as the US-Israel strikes on Iran escalated the conflict, freezing movement from outside and within the region.
2 mins
March 02, 2026
Mint Mumbai
Khamenei dead; war widens
US-Israeli airstrike kills Iran's supreme leader. President Masoud Pezeshkian calls it \"declaration of war against Muslims
3 mins
March 02, 2026
Mint Mumbai
Tiny listings fail at big-league pivot
India’s once busy SME-to-mainboard migration route has slowed sharply.
2 mins
March 02, 2026
Mint Mumbai
THE RISE OF THE YIELD-GENERATING VILLA
A clutch of full-service platforms is helping owners turn their holiday villas into income-generating assets
9 mins
March 02, 2026
Mint Mumbai
Cognizant CEO gets a deal he won for Infy
A multiyear deal of more than $300 million from Daimler Trucks that Cognizant Technology Solutions Corp. snatched from Infosys Ltd last week has one common thread: Ravi Kumar.
2 mins
March 02, 2026
Mint Mumbai
Oil lines blocked, India eyes options
India's crude oil refiners are scouting for new supply sources after Iran's historic announcement of the closure of Strait of Hormuz, three people aware of the development said.
3 mins
March 02, 2026
Mint Mumbai
Mittal unveils succession plan for Bharti
Bharti Enterprises founder and chairman Sunil Bharti Mittal has said that members of the next generation of the Bharti family will become more visible 'at the shareholders'table' in the coming years, signalling a gradual succession plan within the group.
3 mins
March 02, 2026
Mint Mumbai
Is New York under Mamdani bent on overtaxing residents?
Expanded city services come at a cost voters may not understand
3 mins
March 02, 2026
Mint Mumbai
IS INSTITUTIONAL INTEGRITY IN INDIA UNDER THREAT?
This is a deep-rooted conspiracy.
3 mins
March 02, 2026
Mint Mumbai
STCG: Does basic exemption limit apply?
I started investing in equities in 2025 and recently sold some shares, booking a small gain.
2 mins
March 02, 2026
Listen
Translate
Change font size

